News

EU approval for GlaxoSmithKline and Human Genome’s Benlysta; Slowing Advair sales in USA

15-07-2011

There was good news for UK pharma giant GlaxoSmithKline (LSE: GSK) and US partner Human Genome Sciences…

AdvairBenlystaEuropeGlaxoSmithKlineHuman Genome SciencesImmunologicalsMarkets & MarketingNorth AmericaPharmaceuticalRegulationRespiratory and Pulmonary

COMPANY SPOTLIGHT

Menarini

Back to top